Clinical studies of the vaccine from COVID-19 plan to start July 15
The study of vaccines against coronavirus infection in humans in the centre "Vector" is scheduled to begin July 15, the volunteers have already been selected, said General Director of "Vector" Rinat Maksyutov.
"We expect to start clinical trials on July 15. In clinical studies, will bring together 300 volunteers. The work already undertaken on their selection, they fully comply with all the requirements," - said the native in an interview with RIA Novosti.
He said that the first phase of clinical trials will end in September, and while getting good results on safety and immunogenicity of the vaccine will start its registration.
Earlier, Deputy Prime Minister of the Russian Federation Tatyana Golikova called the center "Vector" one of the leaders in creating a vaccine against coronavirus.
Relevant data on the situation of COVID-19 in Russia and the world presented on the portal stopmanager.of the Russian Federation.